Baucus Opposes Linking Comparative Effectiveness Research To Coverage
This article was originally published in The Gray Sheet
Executive Summary
Senate Finance Committee Chairman Max Baucus, D-Mont., plans to propose legislative language for comparative effectiveness research that draws a clear line between information gathering and insurance coverage decisions
You may also be interested in...
Health Reform Options Are Floated In Congress As Sebelius Takes HHS Helm
The effort to accomplish comprehensive health reform this year took several steps forward last week, even as significant barriers remain
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.